Review: Preparation and Application of Magnetic Chitosan Derivatives in Separation Processes

Modified magnetic chitosan materials for heavy metal adsorption: a review

Magnetic chitosan materials have the characteristics of both chitosan and magnetic particle nuclei, showing the characteristics of easy separation and recovery, strong adsorption capacity and high mechanical strength, and have received extensive attention in adsorption, especially in the treatment of heavy metal ions. In order to further improve its performance, many studies have modified magnetic chitosan materials. This review discusses the strategies for the preparation of magnetic chitosan using coprecipitation, crosslinking, and other methods in detail. Besides, this review mainly summarizes the application of modified magnetic chitosan materials in the removal of heavy metal ions in wastewater in recent years. Finally, this review also discusses the adsorption mechanism, and puts forward the prospect of the future development of magnetic chitosan in wastewater treatment.

Preparation of chitosan-coated polystyrene microspheres for the analysis of trace Pb(ii) ions in salt by GF-AAS assisted with solid-phase extraction

Chitosan-coated polystyrene solid-phase extraction fillers.

Chitosan-Based Nanoparticles Against Viral Infections

Viral infections, in addition to damaging host cells, can compromise the host immune system, leading to frequent relapse or long-term persistence. Viruses have the capacity to destroy the host cell while liberating their own RNA or DNA in order to replicate within additional host cells. The viral life cycle makes it challenging to develop anti-viral drugs. Nanotechnology-based approaches have been suggested to deal effectively with viral diseases, and overcome some limitations of anti-viral drugs. Nanotechnology has enabled scientists to overcome the challenges of solubility and toxicity of anti-viral drugs, and can enhance their selectivity towards viruses and virally infected cells, while preserving healthy host cells. Chitosan is a naturally occurring polymer that has been used to construct nanoparticles (NPs), which are biocompatible, biodegradable, less toxic, easy to prepare, and can function as effective drug delivery systems (DDSs). Furthermore, chitosan is Generally Recognized as Safe (GRAS) by the US Food and Drug Administration (U.S. FDA). Chitosan NPs have been used in drug delivery by the oral, ocular, pulmonary, nasal, mucosal, buccal, or vaginal routes. They have also been studied for gene delivery, vaccine delivery, and advanced cancer therapy. Multiple lines of evidence suggest that chitosan NPs could be used as new therapeutic tools against viral infections. In this review we summarize reports concerning the therapeutic potential of chitosan NPs against various viral infections.

The improved antiviral activities of amino-modified chitosan derivatives on Newcastle virus

Chitosan is widely used as a medical material because of its excellent biological activities. However, the low solubility of natural chitosan limited its medicinal activity to some extent. The solubility can be improved by introducing more active groups and lowering molecular weight. Therefore, 6-amine chitosan derivatives were synthesized in this paper since more active groups were introduced to increase the medicinal activity. Those derivatives were characterized by elemental analysis, HPLC, and FT-IR and the antiviral activity was tested by hemagglutination tests. Finally, 6-amine chitosan derivatives improved the antiviral activity, especially after the introduction of bromine ion. When 6-deoxy-6-bromo-N-phthaloyl chitosan was 1 g/L, they reduced the hemagglutination titer of virus to zero. The RT-PCR result showed that the expression level of TNF-α and IFN-β increased significantly, which indicated that the antiviral activity of amino-modified chitosan worked through the stimulation of immune response.

Preparation and characterization of chitosan microparticles for immunoaffinity extraction and determination of enrofloxacin

The use of chitosan microparticles as chromatographic support has received much attention. In this study, the effects of process parameters, namely, chitosan molecular weight, chitosan concentration, molar ratio of amino group to aldehyde group, volume ratio of water to oil phase and stirring speed on the size and size distribution of chitosan microparticles and their application for immunoaffinity extraction were extensively investigated. Size distribution analysis indicated that the average diameter of the microparticles was 124μm with Span value of 1.1. The obtained microparticles exhibited low non-specific adsorption and kept stable in the pH range 4.0-10.0. Immunoaffinity chromatography (IAC) column was prepared by coupling antibody against enrofloxacin (ENR) with chitosan microparticles. Further characterization indicated that the binding capacity of the column was 4392ng ENR/mL gel and the variation of ENR extraction efficiency among columns was less than 5.2%. When challenged with ENR-fortified bovine milk samples, recoveries of ENR by immunoaffinity extraction were found to be in the range of 85.9% to 101.9%, demonstrated the feasibility of the prepared IAC columns for sample clean-up in ENR residue determination.